Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...

Munich [Germany], September 1 (ANI): Tamil Nadu government has inked "key MoUs" with German firms during Tamil Nadu Chief Minister MK Stalin's visit to the country as part of his two-nation tour, with ...

Positive results from the global COAST 1 phase 3 study (clinical study identifier: NCT06130566) showed that amlitelimab, a fully human non-T cell depleting monoclonal antibody that targets OX40-ligand ...

CHENNAI: Union Minister of State for Law and Parliamentary affairs, Arjun Ram Meghwal, speaking at the 16th annual convocation ceremony of the Vels Institute of Science, Technology and Advanced ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...

Tamil Nadu’s Minister for Health and Family Welfare, Ma.Subramanian has written to Union Minister of Civil Aviation pointing out the challenges faced by air travelers in the state. In a detailed ...

Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...

Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...

At a media roundtable convened by the Tamil Nadu Food Safety and Drug Administration Department in Chennai on Thursday (September 4, 2025), experts highlighted the growing need to tackle ‘hidden ...

WASHINGTON – Taking the stage after his landslide victory in South Carolina, Joe Biden hugged his longtime friend Rep. James Clyburn, who gave the former vice president a coveted endorsement three ...